Acquired immunodeficiency syndrome (AIDS) is an immunosuppressive disease that results in life-threatening opportunistic infections and malignancies. Emphasis now has been placed on discovery and development of novel agents, including natural products, against viral and host factors involved in HIV transmission and infection, as well as therapeutics for opportunistic disease pathogens. Among these emerging therapies, natural products are receiving increased attention. Phytochemical investigations of the Rheedia brasiliensis'fruit resulted in the isolation and identification of new potentially bioactive benzophenones. The polyprenilated benzophenones have shown anti-microbial, anti-fungal and anti-HIV activity. However, the mechanism(s) of action of benzophenoes against both HIV and opportunistic infections, including Candida, has yet to be determined. The central objective is to identify the targets that mediate the activity of benzophenones on both HIV and the opportunistic microorganism Candida sp. and to identify the natural compounds with the highest therapeutic index. Mentored k99 phase: The mentored phase of the proposal will be carried out under the mentorship of Prof. Daniel Malamud and Prof. Simone Duarte at New York University. The goal of this phase is to evaluate the antiviral activity and toxicity of benzophenones on immortalized cell lines to establish the therapeutic index for both M-tropic and T-tropic strains of HIV-1;
Aim 2) Identify and characterize specific molecular target(s) by which the benzophenones inhibit HIV infection through interaction with viral gp120 or mammalian cell receptors for the virus using circular dichroism, biosensor analysis and Aim 3) Evaluate and characterize the anti-fungal effect of benzophenones against C. albicans biofilms and determine how these agents affect the content and composition of the polysaccharide matrix, using a combination of fluorescence imaging techniques and Scanning Electron Microscopy. These studies will provide the structural data on modification of the biofilm matrix by the benzophenones, e.g. spatial distribution of biofilm matrix and fungi, and linkage composition of the polysaccharides. This training will provide expertise in virology, structure determination, and cell culture techniques. The acquired knowledge will provide the foundation for transition to an independent career. During the independent phase, I will continue my study with natural molecules to identify additional pathways that may contribute to prevent or treat infectious diseases and assess their potential in vivo.

Public Health Relevance

The development of novel agents derived from natural products that have the ability to inhibit both HIV and HIV-associated pathogens will have major impact on the HIV/AIDS epidemic, both in terms of developing new therapeutic agents, and demonstrating the unique activities of natural products with activity directed against multiple pathogens. The successful completion of the proposed studies has the potential to change the current strategies for dealing with both viral and microbial pandemics as well as promoting the value of therapeutic agents derived from natural products. PROJECT NARRATIVE The development of novel agents derived from natural products that have the ability to inhibit both HIV and HIV-associated pathogens will have major impact on the HIV/AIDS epidemic, both in terms of developing new therapeutic agents, and demonstrating the unique activities of natural products with activity directed against multiple pathogens. The successful completion of the proposed studies has the potential to change the current strategies for dealing with both viral and microbial pandemics as well as promoting the value of therapeutic agents derived from natural products.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Research Transition Award (R00)
Project #
5R00AT006507-05
Application #
8719942
Study Section
Special Emphasis Panel (ZAT1)
Program Officer
Rivera-Rentas, Alberto L
Project Start
2010-09-29
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
5
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Southern California
Department
Dentistry
Type
Schools of Dentistry/Oral Hygn
DUNS #
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Seleem, Dalia; Chen, Emily; Benso, Bruna et al. (2016) In vitro evaluation of antifungal activity of monolaurin against Candida albicans biofilms. PeerJ 4:e2148
Zancopé, Bruna Raquel; Dainezi, Vanessa B; Nobre-Dos-Santos, Marinês et al. (2016) Effects of CO2 laser irradiation on matrix-rich biofilm development formation-an in vitro study. PeerJ 4:e2458
Seleem, Dalia; Benso, Bruna; Noguti, Juliana et al. (2016) In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms. PLoS One 11:e0157188
Silva, Viviam de Oliveira; Lobato, Raquel Vieira; Andrade, Eric Francelino et al. (2015) β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. PLoS One 10:e0134742
Benso, Bruna; Rosalen, Pedro Luiz; Alencar, Severino Matias et al. (2015) Malva sylvestris Inhibits Inflammatory Response in Oral Human Cells. An In Vitro Infection Model. PLoS One 10:e0140331
Patuwo, Christopher; Young, Keane; Lin, Meng et al. (2015) The changing role of HIV-associated oral candidiasis in the era of HAART. J Calif Dent Assoc 43:87-92
Pasetto, Silvana; Pardi, Vanessa; Murata, Ramiro Mendonça (2014) Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. PLoS One 9:e115323
Freires, Irlan de Almeida; Murata, Ramiro Mendonça; Furletti, Vivian Fernandes et al. (2014) Coriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression. PLoS One 9:e99086
Yoo, S; Murata, R M; Duarte, S (2011) Antimicrobial traits of tea- and cranberry-derived polyphenols against Streptococcus mutans. Caries Res 45:327-35